|
[1]
|
COVID-19 Mental Disorders Collaborators (2021) Global Prevalence and Burden of Depressive and Anxiety Disorders in 204 Countries and Territories in 2020 Due to the COVID-19 Pandemic. The Lancet, 398, 1700-1712.
|
|
[2]
|
Tian, W., Yan, G., Xiong, S., Zhang, J., Peng, J., Zhang, X., et al. (2026) Burden of Depressive and Anxiety Disorders in China and Its Provinces, 1990-2021: Findings from the Global Burden of Disease Study 2021. The British Journal of Psychiatry, 228, 18-28. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Yan, N., Zhang, C., Wang, Y., Wang, Y., Luo, Y., Wang, Y., et al. (2025) Chinese Burden of Depressive Disorders from 1990 to 2021 and Prediction for 2030: Analysis of Data from the Global Burden of Disease Study 2021. BMC Psychology, 13, Article No. 30. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Cai, Y.F., Zhaoxiong, Y.Z., Zhu, W. and Wang, H.Y. (2024) Association between Sleep Duration, Depression and Breast Cancer in the United States: A National Health and Nutrition Examination Survey Analysis 2009-2018. Annals of Medicine, 56, Article 2314235. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Kummer, M., Müller, T., Exadaktylos, A.K., Krähenbühl, S. and Liakoni, E. (2021) Characteristics of Presentations to the Emergency Department Following Attempted Suicide with Drugs. International Journal of Environmental Research and Public Health, 18, Article 10232. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Olmer, A., Iancu, I. and Strous, R.D. (2012) Exposure to Antidepressant Medications and Suicide Attempts in Adult Depressed Inpatients. The Journal of Nervous and Mental Disease, 200, 531-534. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
李凌江, 王刚. 中国抑郁障碍防治指南[M]. 2025版. 北京: 人民卫生出版社, 2025: 93-103.
|
|
[8]
|
Malhi, G.S. and Mann, J.J. (2018) Depression. The Lancet, 392, 2299-2312. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
林易玮, 张雨晨, 王澜凝, 李晓白. 抗抑郁抗焦虑药物的药理与临床[J]. 实用药物与临床, 2020, 23(1): 1-4.
|
|
[10]
|
Sabah, K.M.N., Chowdhury, A.W., Islam, M.S., Saha, B.P., Kabir, S.R. and Kawser, S. (2017) Amitriptyline-Induced Ventricular Tachycardia: A Case Report. BMC Research Notes, 10, Article No. 286. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Taylor, D., Poulou, S. and Clark, I. (2024) The Cardiovascular Safety of Tricyclic Antidepressants in Overdose and in Clinical Use. Therapeutic Advances in Psychopharmacology, 14, Article 20451253241243297. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Foresteire, N.P., Howard, C. and Szustkiewicz, K. (2024) Tricyclic Antidepressant and Antipsychotic Toxicity: Clomipramine and Ziprasidone Overdose. Cureus, 16, e63691. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Kontio, T., Salo, A., Kantola, T., Toivonen, L. and Skrifvars, M.B. (2015) Successful Use of Therapeutic Hypothermia after Cardiac Arrest Due to Amitriptyline and Venlafaxine Intoxication. Therapeutic Hypothermia and Temperature Management, 5, 104-109. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Pisani, F., Rosa Pisani, L., Barbieri, M.A., de Leon, J. and Spina, E. (2023) Optimization of Therapy in Patients with Epilepsy and Psychiatric Comorbidities: Key Points. Current Neuropharmacology, 21, 1755-1766. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Protti, M., Mandrioli, R., Marasca, C., Cavalli, A., Serretti, A. and Mercolini, L. (2020) New-Generation, Non-SSRI Antidepressants: Drug-Drug Interactions and Therapeutic Drug Monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and Others. Medicinal Research Reviews, 40, 1794-1832. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Van den Eynde, V., Abdelmoemin, W.R., Abraham, M.M., Amsterdam, J.D., Anderson, I.M., Andrade, C., et al. (2022) The Prescriber’s Guide to Classic MAO Inhibitors (Phenelzine, Tranylcypromine, Isocarboxazid) for Treatment-Resistant Depression. CNS Spectrums, 28, 427-440. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Foong, A.L., Grindrod, K.A., Patel, T. and Kellar, J. (2018) Demystifying Serotonin Syndrome (or Serotonin Toxicity). Canadian Family Physician, 64, 720-727.
|
|
[18]
|
Gillman, K. (2017) “Much Ado about Nothing”: Monoamine Oxidase Inhibitors, Drug Interactions, and Dietary Tyramine. CNS Spectrums, 22, 385-387. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
徐家玥, 秦舟, 徐珽. 常用抗抑郁药物的临床应用与展望[J]. 临床药物治疗杂志, 2018, 16(5): 9-13.
|
|
[20]
|
Scotton, W.J., Hill, L.J., Williams, A.C. and Barnes, N.M. (2019) Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions. International Journal of Tryptophan Research, 12, Article 1178646919873925. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Medrihan, L., Sagi, Y., Inde, Z., Krupa, O., Daniels, C., Peyrache, A., et al. (2017) Initiation of Behavioral Response to Antidepressants by Cholecystokinin Neurons of the Dentate Gyrus. Neuron, 95, 564-576.e4. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Sharif, A.F., Almulhim, M.N.M., Almosabeh, H.M.A., Alshammasy, M.E.A., Aljeshi, A.M.A., Mufti, T.M.A., et al. (2024) Predictors of Serotonin Syndrome in Acute Poisoning with 5-Hydroxytryptamine Modulators. Toxics, 12, Article 550. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Schifano, F., Chiappini, S., Miuli, A., Corkery, J.M., Scherbaum, N., Napoletano, F., et al. (2021) New Psychoactive Substances (NPS) and Serotonin Syndrome Onset: A Systematic Review. Experimental Neurology, 339, Article 113638. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Mikkelsen, N., Damkier, P. and Pedersen, S.A. (2023) Serotonin Syndrome—A Focused Review. Basic & Clinical Pharmacology & Toxicology, 133, 124-129. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Chiew, A.L. and Isbister, G.K. (2025) Management of Serotonin Syndrome (Toxicity). British Journal of Clinical Pharmacology, 91, 654-661. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Kraai, E.P. and Seifert, S.A. (2015) Citalopram Overdose: A Fatal Case. Journal of Medical Toxicology, 11, 232-236. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Cooke, M.J. and Waring, W.S. (2013) Citalopram and Cardiac Toxicity. European Journal of Clinical Pharmacology, 69, 755-760. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Eizadi-Mood, N., Miranzade, N., Haddad, S., Aliabadi, M.G., Golshiri, P. and Meamar, R. (2025) Comparison of Clinicodemographic Characteristics in Patients with Selective Serotonin Reuptake Inhibitors Poisoning: A Cross-Sectional Study. Medical Journal Armed Forces India, 81, 72-79. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Shelton, R.C. (2019) Serotonin and Norepinephrine Reuptake Inhibitors. In: Handbook of Experimental Pharmacology, Springer, 145-180. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Taylor, D. (2010) Venlafaxine and Cardiovascular Toxicity. British Medical Journal, 340, c411. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Kobylianskii, J. and Wu, P.E. (2021) Venlafaxine-Induced Hypoglycemia. Canadian Medical Association Journal, 193, E568. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Cho, C.K., Kang, P., Jang, C.G., Lee, S.Y., et al. (2024) PBPK Modeling to Predict the Pharmacokinetics of Venlafaxine and Its Active Metabolite in Different CYP2D6 Genotypes and Drug–drug Interactions with Clarithromycin and Paroxetine. Archives of Pharmacal Research, 47, 481-504. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Isbister, G.K., Polanski, R., Cooper, J.M., Keegan, M. and Isoardi, K.Z. (2022) Duloxetine Overdose Causes Sympathomimetic and Serotonin Toxicity without Major Complications. Clinical Toxicology, 60, 1019-1023. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Kasper, S. and Pail, G. (2010) Milnacipran: A Unique Antidepressant? Neuropsychiatric Disease and Treatment, 6, 23-31.
|
|
[35]
|
Clark, A., Tate, B., Urban, B., Schroeder, R., Gennuso, S., Ahmadzadeh, S., et al. (2023) Bupropion Mediated Effects on Depression, Attention Deficit Hyperactivity Disorder, and Smoking Cessation. Health Psychology Research, 11, 1. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Schwasinger-Schmidt, T.E. and Macaluso, M. (2019) Other Antidepressants. In: Handbook of Experimental Pharmacology, Springer, 325-355. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Rianprakaisang, T.N., Prather, C.T., Lin, A.L., Murray, B.P. and Hendrickson, R.G. (2021) Factors Associated with Seizure Development after Bupropion Overdose: A Review of the Toxicology Investigators Consortium. Clinical Toxicology, 59, 1234-1238. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Costa, R., Oliveira, N.G. and Dinis-Oliveira, R.J. (2019) Pharmacokinetic and Pharmacodynamic of Bupropion: Integrative Overview of Relevant Clinical and Forensic Aspects. Drug Metabolism Reviews, 51, 293-313. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Stall, N., Godwin, J. and Juurlink, D. (2014) Bupropion Abuse and Overdose. Canadian Medical Association Journal, 186, 1015-1015. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Caillier, B., Pilote, S., Castonguay, A., Patoine, D., Ménard-Desrosiers, V., Vigneault, P., et al. (2012) QRS Widening and QT Prolongation under Bupropion: A Unique Cardiac Electrophysiological Profile. Fundamental & Clinical Pharmacology, 26, 599-608. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Hassanein, E.H.M., Althagafy, H.S., Baraka, M.A., Abd-Alhameed, E.K. and Ibrahim, I.M. (2024) Pharmacological Update of Mirtazapine: A Narrative Literature Review. Naunyn-Schmiedeberg’s Archives of Pharmacology, 397, 2603-2619. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Berling, I. and Isbister, G.K. (2014) Mirtazapine Overdose Is Unlikely to Cause Major Toxicity. Clinical Toxicology, 52, 20-24. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Wang, Y.Q., Jiang, Y.J., Zou, M.S., Liu, J., et al. (2022) Antidepressant Actions of Melatonin and Melatonin Receptor Agonist: Focus on Pathophysiology and Treatment. Behavioural Brain Research, 420, Article 113724. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Konstantakopoulos, G., Dimitrakopoulos, S. and Michalopoulou, P.G. (2020) The Preclinical Discovery and Development of Agomelatine for the Treatment of Depression. Expert Opinion on Drug Discovery, 15, 1121-1132. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Freiesleben, S.D. and Furczyk, K. (2015) A Systematic Review of Agomelatine-Induced Liver Injury. Journal of Molecular Psychiatry, 3, Article No. 4. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Husak, N., Leonard, J.B., Seung, H. and Klein-Schwartz, W. (2022) Single-Substance Trazodone Exposures Reported to US Poison Centers from 2000 to 2019. Clinical Toxicology, 60, 1032-1038. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Lee, S., Lee, H.A., Kim, S.J. and Kim, K.S. (2016) Cellular Mechanisms for Trazodone-Induced Cardiotoxicity. Human & Experimental Toxicology, 35, 501-510. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Khouzam, H.R. (2017) A Review of Trazodone Use in Psychiatric and Medical Conditions. Postgraduate Medicine, 129, 140-148. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Calvi, A., Fischetti, I., Verzicco, I., Belvederi Murri, M., Zanetidou, S., Volpi, R., et al. (2021) Antidepressant Drugs Effects on Blood Pressure. Frontiers in Cardiovascular Medicine, 8, Article 704281. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
王辉蓉, 王争秒, 耿文博. 伏硫西汀和度洛西汀对抑郁症患者的治疗效果､安全性及认知功能的影响[J]. 中华灾害救援医学, 2024, 11(12): 1460-1463.
|
|
[51]
|
Zanos, P., Moaddel, R., Morris, P.J., Riggs, L.M., Highland, J.N., Georgiou, P., et al. (2018) Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms. Pharmacological Reviews, 70, 621-660. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Zhou, J.S., Peng, G.F., Liang, W.D., Chen, Z., et al. (2023) Recent Advances in the Study of Anesthesia and Analgesia-Related Mechanisms of S-Ketamine. Frontiers in Pharmacology, 14, Article 1228895. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
李宇蒙, 杜小雨, 邱博, 吴惠珍. 托鲁地文拉法辛治疗抑郁症的药理作用与临床评价[J]. 中国临床药理学与治疗学, 2025, 30(3): 419-426.
|
|
[54]
|
Soria-Chacartegui, P., Villapalos-García, G., Zubiaur, P., Abad-Santos, F. and Koller, D. (2021) Genetic Polymorphisms Associated with the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone. Frontiers in Pharmacology, 12, Article 711940. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Serrano, W.C. and Maldonado, J. (2021) The Use of Physostigmine in the Diagnosis and Treatment of Anticholinergic Toxicity after Olanzapine Overdose: Literature Review and Case Report. Journal of the Academy of Consultation-Liaison Psychiatry, 62, 285-297. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Fang, F., Sun, H., Wang, Z., Ren, M., Calabrese, J.R. and Gao, K. (2016) Antipsychotic Drug-Induced Somnolence: Incidence, Mechanisms, and Management. CNS Drugs, 30, 845-867. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
洪卫兰, 卢奎, 张文渊, 黎颖然. 氟哌噻吨美利曲辛片不良反应文献回顾性分析[J]. 药品评价, 2022, 19(13): 829-832.
|
|
[58]
|
McIntyre, R.S. and Jain, R. (2024) Glutamatergic Modulators for Major Depression from Theory to Clinical Use. CNS Drugs, 38, 869-890. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Iosifescu, D.V., Jones, A., O’Gorman, C., Streicher, C., et al. (2022) Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients with Major Depressive Disorder: A Phase 3 Randomized Clinical Trial (GEMINI). The Journal of Clinical Psychiatry, 83, 21m14345.
|
|
[60]
|
王娜, 刘俊宏, 俞纲, 苏瑞斌. γ-氨基丁酸A型受体变构调节剂研究进展[J]. 中国药理学与毒理学杂志, 2022, 36(6): 466-472.
|
|
[61]
|
Phillips, B., O’Connor, C. and St. Onge, E. (2024) Gepirone: A New Extended-Release Oral Selective Serotonin Receptor Agonist for Major Depressive Disorder. Journal of Pharmacy Technology, 40, 230-235. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Cui, Y.H. and Zheng, Y. (2016) A Meta-Analysis on the Efficacy and Safety of St John’s Wort Extract in Depression Therapy in Comparison with Selective Serotonin Reuptake Inhibitors in Adults. Neuropsychiatric Disease and Treatment, 12, 1715-1723. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Scholz, I., Liakoni, E., Hammann, F., Grafinger, K.E., Duthaler, U., Nagler, M., et al. (2021) Effects of Hypericum perforatum (St John’s Wort) on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban in Humans. British Journal of Clinical Pharmacology, 87, 1466-1474. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Zhang, M. and Bai, X. (2022) Shugan Jieyu Capsule in Post-Stroke Depression Treatment: From Molecules to Systems. Frontiers in Pharmacology, 13, Article 821270. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Amiri, H., Zamani, N., Hassanian-Moghaddam, H. and Shadnia, S. (2016) Cardiotoxicity of Tricyclic Antidepressant Treated by 2650 mEq Sodium Bicarbonate: A Case Report. JRSM Cardiovascular Disease, 5, Article 2048004016682178.
|
|
[66]
|
Tsujikawa, S., Matsuura, T., Hori, K., Mori, T., Kuno, M. and Nishikawa, K. (2018) Superior Efficacy of Lipid Emulsion Infusion over Serum Alkalinization in Reversing Amitriptyline-Induced Cardiotoxicity in Guinea Pig. Anesthesia & Analgesia, 126, 1159-1169. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
廖睿, 陈宝安, 许钰唯, 刘志文, 张伟, 陶莉莉, 段永春. 抗抑郁药物中毒的诊治进展[J]. 中外医疗, 2021, 40(14): 195-198.
|
|
[68]
|
Petroianu, G.A. (2022) Hyperthermia and Serotonin: The Quest for a “Better Cyproheptadine”. International Journal of Molecular Sciences, 23, Article 3365. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Dutta, S., Buciuc, A.G., Barry, P. and Padilla, V. (2025) A Narrative Review on Toxidromes in the Psychiatric Population: Implications for Overdose Prevention. Journal of Clinical Medicine, 14, Article 6160. [Google Scholar] [CrossRef]
|
|
[70]
|
石汉文. 抗抑郁药物中毒救治进展[J]. 中国实用内科杂志, 2014, 34(11): 1072-1073.
|